Post ESC Congress Highlights 2024 – Session 2 - Resources

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

This webinar is broadcast in association with the British Journal of Cardiology; our media partner is GPnotebook, who have had no input into the content of the activity.

ESC Congress 2024 highlights - A UK perspective

On demand

Simplifying the management of heart failure across the ejection fraction

Presenter: Prof Pardeep Jhund, Professor of Cardiology & Epidemiology, University of Glasgow

This is an educational, promotional video created and funded by AstraZeneca, intended for UK HCPs only.

Prescribing information for Forxiga (dapagliflozin) in Great Britain is available here

Prescribing information for Forxiga (dapagliflozin) in Northern Ireland is available here

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033

AstraZeneca has provided sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.

GB-59733 | October 2024